TUTORIAL SCREENING Dr. Salwa Tayel, Dr. A. Almazam, Dr Afzal Mahmood

Slides:



Advertisements
Similar presentations
Screening and Prevention
Advertisements

Clinical Effectiveness: Interpreting test results Nick Price 17 th October 2006.
SCREENING CHP400: Community Health Program-lI Mohamed M. B. Alnoor
How do we delay disease progress once it has started?
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
What Happens to the Performance of a Diagnostic Test when the Disease Prevalence and the Cut-Point Change? Pathological scores Healthy scores Healthy population.
SCREENING FOR DISEASE Nigel Paneth. THREE KEY MEASURES OF VALIDITY 1.SENSITIVITY 2.SPECIFICITY 3.PREDICTIVE VALUE.
Diagnosis, screening and prevention. Puzzle Virus present randomly in 1 in 1000 population Test for virus 99% reliable –i.e. misses 1% of infected individuals.
1 Comunicación y Gerencia 18/4/2011Dr Salwa Tayel (Screening) بسم الله الرحمن الرحيم.
Screening. Screening refers to the application of a test to people who are as yet asymptomatic for the purpose of classifying them with respect to their.
Baye’s Rule and Medical Screening Tests. Baye’s Rule Baye’s Rule is used in medicine and epidemiology to calculate the probability that an individual.
Prof. Wasantha Gunathunga.  Primary  Secondary  Tertiary.
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
Screening Manish Chaudhary BPH(IOM), MPH(BPKIHS)
(Medical) Diagnostic Testing. The situation Patient presents with symptoms, and is suspected of having some disease. Patient either has the disease or.
Screening and Early Detection Epidemiological Basis for Disease Control – Fall 2001 Joel L. Weissfeld, M.D. M.P.H.
Screening Sherine Shawky, MD, Dr.PH Assistant Professor Public Health King Abdulaziz University College of Medicine
Epidemiology made easy -or- “Lies, damn lies, and statistics”
Statistics in Screening/Diagnosis
Dr. Afnan Younis & A. Al Mazam Dr Afzal Mahmood, Dr Salwa A Tayel KSU, Department of Family & Community Medicine (1434, 2013) TUTORIAL Community Medicine.
Principles and Predictive Value of Screening. Objectives Discuss principles of screening Describe elements of screening tests Calculate sensitivity, specificity.
Statistics for nMRCGP Jo Kirkcaldy. Curriculum Condensed Knowledge Incidence and prevalence Specificity and sensitivity Positive and negative predictive.
SCREENING Asst. Prof. Sumattna Glangkarn RN, MSc. (Epidemiology), PhD (Nursing studies)
Screening and Diagnostic Testing Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State University.
Statistics. Statistics = everything you need to know, but continually want to forget!!!!
BIOE 301 Lecture Thirteen. Review of Lecture 12 The burden of cancer Contrasts between developed/developing world How does cancer develop? Cell transformation.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Screening Puja Myles
SCREENING Dr. Aliya Hisam Community Medicine Dept. Army Medical College, RWP.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
Principles of Screening
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
HSS4303B – Intro to Epidemiology Feb 8, Agreement.
Diagnostic Tests Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /7/20151.
Positive Predictive Value and Negative Predictive Value
Practical application. Population A ELISA test is applied to a million people where 1% are infected with HIV. Of the million people, 10,000 would be infected.
1 Wrap up SCREENING TESTS. 2 Screening test The basic tool of a screening program easy to use, rapid and inexpensive. 1.2.
Natural History & Spectrum of Diseases
Predictive values prevalence CK and acute myocardial infarction –sensitivity 70% –specificity 80% –prevalence - 40% –prevalence - 20% –PPV and NPV.
Assist. Prof. Dr. Memet IŞIK Ataturk University Medical Faculty Department of Family Medicine Class 2:
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
Evaluation of Diagnostic Tests & ROC Curve Analysis PhD Özgür Tosun.
12/12/2009Dr. Salwa Tayel1 Comunicación y Gerencia.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Communicating Risk.
DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M
بسم الله الرحمن الرحيم.
Evidence-Based Medicine
Class session 7 Screening, validity, reliability
Dr. Tauseef Ismail Assistant Professor Dept of C Med. KGMC
Comunicación y Gerencia
Measuring Success in Prediction
How do we delay disease progress once it has started?
How do we judge efficacy of a screening test?
دكتر محسن ميرزائي MD , MPH
Refining Probability Test Informations Vahid Ashoorion MD. ,MSc,
Dr. Hannah Jordan Lecturer in Public Health ScHARR
Figure 1. Table for calculating the accuracy of a diagnostic test.
Patricia Butterfield & Naomi Chaytor October 18th, 2017
An Assessment of the Screening Performance of a Single-Item Measure of Depression From the Edmonton Symptom Assessment Scale Among Chronically Ill Hospitalized.
Independent Analysis FAIL PASS Initial Screen 77, ,956 25
Positive predictive value of screening tests
Digital 2D versus Tomosynthesis Screening Mammography among Women Aged 65 and Older in the United States Screening mammography performance metrics are.
Screening and Prevention
Evidence Based Diagnosis
Clinical Effectiveness: sensitivity, specificity and PPV
Presentation transcript:

TUTORIAL SCREENING Dr. Salwa Tayel, Dr. A. Almazam, Dr Afzal Mahmood KSU, Department of Family & Community Medicine (November, 2013) November 26, 2013

Calculating sensitivity and specificity of a screening test November 26, 2013

Calculating sensitivity and specificity of a screening test November 26, 2013

Calculating sensitivity and specificity of a screening test November 26, 2013

Calculating sensitivity and specificity of a screening test Sensitivity = [a/(a+c)] X 100 = 95% What is the meaning of this result? Specificity = [d/(b+d)] X 100 = 95% November 26, 2013

How to interpret results Sensitivity: a / (a + c) Sensitivity = 95% i.e. Screening test will correctly identify 95% of all true cases. Specificity: d / (b + d) Specificity = 95% i.e. Screening test will correctly classify 95% of all non-cases as being disease free. November 26, 2013

Calculating PPV and NPV November 26, 2013

Calculating PPV and NPV P.P.V. = a/(a+b) = 19/(19+99) =16% What is the meaning of this result? N.P.V. = d/(c+d) = 1881/(1881+1)=99.99% November 26, 2013

How to interpret results P.P.V. = a/(a+b) = 19/(19+99) =16% Among persons who screen positive, 16% are found to have the disease. N.P.V. = d/(c+d) = 1881/(1881+1)=99.99% Among persons who screen negative, 99.9% are found to be disease free. November 26, 2013

Calculating the PPV/NPV of a screening test November 26, 2013

Calculating the PPV/NPV of a screening test November 26, 2013

Screening test (Mammography) Comparison of mammography results with findings from surgical excisional biopsies in women without palpable breast masses Total Gold standard (Surgical biopsy) Screening test (Mammography) No cancer Cancer 65 49 16 Positive 935 931 4 Negative 1000 980 20

Screening test (Mammography) Comparison of mammography results with findings from surgical excisional biopsies in women without palpable breast masses Total Gold standard (Surgical biopsy) Screening test (Mammography) No cancer Cancer TP+FP 65 FP 49 TP 16 Positive FN+TN 935 TN 931 FN 4 Negative 1000 FP+TN 980 TP+FN 20

Positive Predictive Value Negative Predictive Value Calculate: Sensitivity Specificity Positive Predictive Value Negative Predictive Value False Positive rate False Negative rate Disease prevalence November 26, 2013

Following is a diagram that may help you to remember how to calculate sensitivity, specificity and the predictive values. November 26, 2013

Calculations: Sensitivity: 16/20*100 = 80% Specificity: 931/980*100 = 95% PPV: 16/65*100 = 24.6% PNV: 931/935*100 = 99.6% False Positive rate = 49/980*100 = 5% False Negative rate = 4/20*100=20% Disease prevalence 20/1000*100=2% November 26, 2013

Effectiveness of the Screening Program DISCUSSION Effectiveness of the Screening Program DISCUSS: The factors that influence effectiveness of Screening and Screening Programs November 26, 2013

factors that influence effectiveness of Screening and Screening Programs Accurate Simple easy to implement Screening Inexpensive Acceptable to those who agree to be tested Safe The disease is of public health significance High Prevalence (see the next slide for relationship between prevalence and predictive value of screening) Significant in terms of morbidity, mortality, disability, cost to the community Availability of effective treatment Health system capable of providing services to all November 26, 2013

Factors affecting the PPV/NPV of a screening test Prevalence (%) Sensitivity Specificity PPV 0.1 90% 95% 1.8% 1.0 90% 95% 15.4% 5.0 90% 95% 48.6% 50.0 90% 95% 94.7% November 26, 2013